Novel Inhibitors of the Histone-Methyltransferase DOT1L Show Potent Antileukemic Activity in Patient-derived Xenografts (ChIP-seq dataset)

Novel Inhibitors of the Histone-Methyltransferase DOT1L Show Potent Antileukemic Activity in Patient-derived Xenografts

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML [RNA-seq]

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML

Acquired MEN1 mutations mediate resistance to Menin inhibition [RNA-seq]

Acquired MEN1 mutations mediate resistance to Menin inhibition [CHIP-seq]

Acquired MEN1 mutations mediate resistance to Menin inhibition.

The menin inhibitor SNDX-5613 for KMT2A rearranged or NPM1 mutant leukemia